Evidence map›Paper›PMID 33488079›Full record

ArticleInternational journal of nanomedicine2021

Enhanced Photothermal-Photodynamic Therapy by Indocyanine Green and Curcumin-Loaded Layered MoS

Shuai Li, Shuping Yang, Chong Liu, Jintong He, Tian Li, Changhui Fu, Xianwei Meng, Haibo Shao

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. MoSBioactive materials · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Magnetite FeInternational journal of nanomedicine · 2021
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shuai Li *Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, People's Republic of China.
Shuping Yang *Department of Pain Medicine, The First Hospital of China Medical University, Shenyang 110001, Liaoning, People's Republic of China.
Chong LiuDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, People's Republic of China.
Jintong HeDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, People's Republic of China.
Tian LiDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, People's Republic of China.
Changhui FuLaboratory of Controllable Preparation and Application of Nanomaterials, Chinese Academy of Sciences Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, People's Republic of China.
Xianwei MengLaboratory of Controllable Preparation and Application of Nanomaterials, Chinese Academy of Sciences Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, People's Republic of China.
Haibo ShaoDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, People's Republic of China.
China Medical University · CNFirst Hospital of China Medical University · CNTechnical Institute of Physics and Chemistry · CN

Funding

Chronic Intermittent Ethanol and Kv4.2 ChannelsR01AA022701 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHANDLER, L JUDSON · 2015 to 2019
$1.7M
NIAAA NIH HHS R01 AA022701
6 · The paper itself

Abstract

purposeP-glycoprotein (P-gp), which is highly expressed in liver cancer cells, is one of the obstacles for the treatment of cancer. In this study, we have prepared and characterized a kind of novel ICG&Cur@MoS

methodsIn this work, plenty of studies including drug release, acute toxicity, Western blot, real-time PCR, cell viability, therapeutic experiment in vivo, immunofluorescence and so on were conducted to test the antitumor potential of ICG&Cur@MoS

resultsThe ICG&Cur@MoS

conclusionIn conclusion, we have successfully synthesized ICG&Cur@MoS

Indexed as

AnimalsATP Binding Cassette Transporter, Subfamily B, Member 1Cell Line, TumorCurcuminDisulfidesDrug LiberationHumansIndocyanine GreenMolybdenumNanoparticlesPhotochemotherapyATP Binding Cassette Transporter, Subfamily B, Member 1CurcuminDisulfidesIndocyanine GreenMolybdenummolybdenum disulfidecurcuminhepatocellular carcinomaindocyanine greenMoS2P-glycoproteinphotothermal-photodynamic therapy

Identifiers

PMID33488079
PMCPMC7815073
OpenAlexW3118608329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.